Skip to content
10-Q

Quarterly Report

Bionano Genomics, Inc. BNGO

0001411690-25-000093

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 5, 2025 10.18M sh
Shares Diluted Q3 2025 · Sep 30, 2025 5.34M sh
Shares Diluted Q3 2025 · Sep 30, 2025 3.83M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 1.43M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 1.15M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$12.17M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$62.42M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $3.07M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $9.17M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $8.79M
Stockholders Equity Q3 2025 · Sep 30, 2025 $49.8M
Stockholders Equity Q3 2025 · Jun 30, 2025 $45.37M
Stockholders Equity Q3 2025 · Mar 31, 2025 $48.19M
Stockholders Equity Q3 2025 · Dec 31, 2024 $35.38M
Stockholders Equity restated Q3 2025 · Sep 30, 2024 $48.86M
Stockholders Equity restated Q3 2025 · Jun 30, 2024 $80.34M
Stockholders Equity restated Q3 2025 · Mar 31, 2024 $82.77M
Stockholders Equity Q3 2025 · Dec 31, 2023 $96.16M
Current Liabilities Q3 2025 · Sep 30, 2025 $22.98M
Current Liabilities Q3 2025 · Dec 31, 2024 $37.34M
Total Liabilities Q3 2025 · Sep 30, 2025 $29.26M
Total Liabilities Q3 2025 · Dec 31, 2024 $41.3M
Current Assets Q3 2025 · Sep 30, 2025 $48.8M
Current Assets Q3 2025 · Dec 31, 2024 $39.49M
Total Assets Q3 2025 · Sep 30, 2025 $79.06M
Total Assets Q3 2025 · Dec 31, 2024 $76.67M
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.59
Eps Diluted Q3 2025 · Sep 30, 2025 −$4.82
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$30.92
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$80.18
Eps Basic Q3 2025 · Sep 30, 2025 −$1.59
Eps Basic Q3 2025 · Sep 30, 2025 −$4.82
Eps Basic restated Q3 2025 · Sep 30, 2024 −$30.92
Eps Basic restated Q3 2025 · Sep 30, 2024 −$80.18
Sga Expense Q3 2025 · Sep 30, 2025 $9.06M
Sga Expense Q3 2025 · Sep 30, 2025 $26.44M
Sga Expense Q3 2025 · Sep 30, 2024 $9.46M
Sga Expense Q3 2025 · Sep 30, 2024 $40.11M
Rd Expense Q3 2025 · Sep 30, 2025 $2.84M
Rd Expense Q3 2025 · Sep 30, 2025 $8.15M
Rd Expense Q3 2025 · Sep 30, 2024 $4.72M
Rd Expense Q3 2025 · Sep 30, 2024 $21.33M
Net Income Q3 2025 · Sep 30, 2025 −$8.5M
Net Income Q3 2025 · Sep 30, 2025 −$18.46M
Net Income Q3 2025 · Jun 30, 2025 −$6.86M
Net Income Q3 2025 · Mar 31, 2025 −$3.1M
Net Income Q3 2025 · Sep 30, 2024 −$44.25M
Net Income Q3 2025 · Sep 30, 2024 −$91.89M
Net Income Q3 2025 · Jun 30, 2024 −$16.22M
Net Income Q3 2025 · Mar 31, 2024 −$31.42M
Operating Income Q3 2025 · Sep 30, 2025 −$8.54M
Operating Income Q3 2025 · Sep 30, 2025 −$24.8M
Operating Income Q3 2025 · Sep 30, 2024 −$43.9M
Operating Income Q3 2025 · Sep 30, 2024 −$92.04M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $4M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $10.77M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $14.52M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $25.65M
Revenue Q3 2025 · Sep 30, 2025 $7.37M
Revenue Q3 2025 · Sep 30, 2025 $20.56M
Revenue Q3 2025 · Sep 30, 2024 $6.07M
Revenue Q3 2025 · Sep 30, 2024 $22.61M